Mobile

A 52-WEEK OPEN-LABEL SAFETY STUDY OF PD 0332334 IN SUBJECTS WITH GENERALIZED ANXIETY DISORDER

Update Il y a 4 ans
Reference: EUCTR2008-004443-11

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

Primary Objectives: • To assess the long-term safety and tolerability of 350 to 600 mg/day of PD-0332334 dosed BID in subjects with GAD.

Inclusion criteria

  • Generalized Anxiety Disorder

Links